BRAF and thyroid gland follicular carcinoma: There are other mutations of the BRAF gene, such as K601E, which displays lower oncogenic activity in vitro than V600E; indeed, the kinase activity of V600E is 2.5 times greater than that of the K601E that has been identified in follicular adenomas and, more rarely, in some follicular carcinomas [16, 17].